Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Molecular Therapy. Methods & Clinical Development
|
April 27, 2022
Characterizing piggyBat-a transposase for genetic modification of T cells
Gaurav Sutrave, Ning Xu, Tiffany C Y Tang, et al.
Stem Cells and Development
|
October 21, 2014
Small-molecule inhibitor of glycogen synthase kinase 3β 6-Bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice
Sylvie Shen, Ning Xu, Guy Klamer, et al.
International Journal of Oncology
|
June 26, 2008
siRNA targeting the IRF2 transcription factor inhibits leukaemic cell growth
Ailyn Choo, Patricia Palladinetti, Tiffany Holmes, et al.
Journal of Proteomics
|
November 9, 2013
Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
Patrick Y Kim, Owen Tan, Sonya M Diakiw, et al.
Science Translational Medicine
|
May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia
Ernest Moles, Christopher B Howard, Pie Huda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Jingwei Chen, Christopher Nelson, Matthew Wong, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Molecular Therapy. Methods & Clinical Development
|
April 27, 2022
Characterizing piggyBat-a transposase for genetic modification of T cells
Gaurav Sutrave, Ning Xu, Tiffany C Y Tang, et al.
Stem Cells and Development
|
October 21, 2014
Small-molecule inhibitor of glycogen synthase kinase 3β 6-Bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice
Sylvie Shen, Ning Xu, Guy Klamer, et al.
International Journal of Oncology
|
June 26, 2008
siRNA targeting the IRF2 transcription factor inhibits leukaemic cell growth
Ailyn Choo, Patricia Palladinetti, Tiffany Holmes, et al.
Journal of Proteomics
|
November 9, 2013
Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
Patrick Y Kim, Owen Tan, Sonya M Diakiw, et al.
Science Translational Medicine
|
May 17, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia
Ernest Moles, Christopher B Howard, Pie Huda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2020
Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Jingwei Chen, Christopher Nelson, Matthew Wong, et al.
Page
of 3